Navigation Links
Former Life Technologies and BD Biosciences Executive John L. "Kip" Miller Joins Solulink's Board of Directors
Date:8/28/2013

SAN DIEGO, Aug. 28, 2013 /PRNewswire/ -- Solulink, Inc., an emerging life science tools company with expertise in biomolecular linking, today announced John L. "Kip" Miller has joined the company's Board of Directors. The addition of Mr. Miller to the Solulink board will be instrumental as the company commences commercialization of its HybriLink™ technology.

(Logo: http://photos.prnewswire.com/prnh/20130828/LA71117LOGO)

The HybriLink technology solves the 'missing color' problem: the inability to find the needed antibody labeled with the right fluorophore (color).  Often, the desired combination is not commercially available.  By providing a simple way to mix and match any fluorophore with any antibody on demand, just-in-time at the point-of-use, HybriLink dramatically streamlines the development and expansion of multicolor flow panels for flow cytometry research labs. Solulink believes that HybriLink's ability to offer all antibodies in all fluorophores – including the next generation of emerging fluorophores – resolves a fundamental challenge in flow cytometry and will expand the overall flow cytometry reagents market size.

Mr. Miller brings a solid track record of life science leadership with a strong background in commercial operations, and extensive experience in the life science research and diagnostic markets. Most recently, Mr. Miller served as President of Genetic Systems at Life Technologies. From 2008 to 2011, he served as Senior Vice President of Biodiscovery at Invitrogen Corporation, which merged with Applied Biosystems in 2008 to form Life Technologies. Prior to joining Invitrogen Corporation, Mr. Miller served in various capacities for BD including VP GM of BD Biosciences Research Cell Analysis Business, VP GM of BD Pharmingen and VP Sales and Service the Americas'. Mr. Miller holds a B.S. in Packaging Engineering from Michigan State University.

Currently, Mr. Miller is a co-founder and member of the Board of Directors at Tonbo Biosciences, and a member of the Board of Directors at Firefly BioWorks.

"We are delighted to welcome Kip to the Solulink board, and excited by the prospect of working with this dynamic leader to advance Solulink's new HybriLink technology," said Walt Young, Solulink's Chairman of the Board. "Kip's perspective and expertise will be invaluable as Solulink pursues its new HybriLink products for flow cytometry and implements their commercialization strategy."

About Solulink
Solulink, a privately-held life science tools company, develops, manufactures and markets proprietary, next generation linking technology for the development and improvement of products in the research assay and diagnostic markets. Solulink's latest innovation, the HybriLink Technology, improves the capabilities of end users, developers and suppliers to utilize the growing wide variety of detection technologies for research and diagnostic life science assays. Solulink markets their products directly and through distributors and licensing partners world-wide.


'/>"/>
SOURCE Solulink, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Former Head of UK Medicines & Healthcare Products Regulatory Agency (MHRA) Sir Alasdair Breckenridge Joins NDA Partners
2. Former COO and CSO of IDEXX Laboratories, Inc. Joins Board of Directors for Vet-Stem, Inc.
3. MEI Pharma Adds Former YM BioSciences CEO Nick Glover To Board Of Directors
4. Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
5. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
6. Utah, There is No Better Place U.S. Chamber of Commerce Ranks Utah as the Top Performer in the Nation
7. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
8. Delta Point Strengthens Management and Expands Consultancy Services with Addition of Former AstraZeneca Executive Michael Hickey
9. Non-Intrusive Black Mold Removal Procedure Released By Former Mold Remediation Specialist, MyCleaningProducts.com Explains
10. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
11. Former Stryker CEO Takes Reins at sBioMed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/23/2017)... La. (PRWEB) , ... March 23, 2017 , ... ... industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as ... customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has ...
(Date:3/22/2017)... , March 22, 2017  UBM and the ... announce their extended partnership and the third annual Massachusetts ... by the 21 st Annual MassMEDIC Conference ... place May 3-4, 2017. MassMEDIC ... Association (ADVAMED) President and CEO, Scott Whitaker ...
(Date:3/22/2017)... 22, 2017 The global chronic ... research report by Transparency Market Research (TMR). The top ... and AbbVie Inc., accounted for a share of only ... in this market are focusing aggressively on mergers, acquisitions, ... is likely to lead to market consolidation in the ...
Breaking Biology Technology:
(Date:2/27/2017)... , Feb. 27, 2017   Strategic Cyber ... announced it has led a $3.5 million investment in  ... platform. Strategic Cyber Ventures is DC based and is ... Hank Thomas . Ron Gula , also ... Ventures, also participated in this series A round of ...
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):